320 related articles for article (PubMed ID: 17225020)
1. Treatment of ocular cicatricial pemphigoid with the tumour necrosis factor alpha antagonist etanercept.
Prey S; Robert PY; Drouet M; Sparsa A; Roux C; Bonnetblanc JM; Bédane C
Acta Derm Venereol; 2007; 87(1):74-5. PubMed ID: 17225020
[No Abstract] [Full Text] [Related]
2. Successful biologic treatment of ocular mucous membrane pemphigoid with anti-TNF-alpha.
John H; Whallett A; Quinlan M
Eye (Lond); 2007 Nov; 21(11):1434-5. PubMed ID: 17693996
[No Abstract] [Full Text] [Related]
3. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.
Canizares MJ; Smith DI; Conners MS; Maverick KJ; Heffernan MP
Arch Dermatol; 2006 Nov; 142(11):1457-61. PubMed ID: 17116836
[TBL] [Abstract][Full Text] [Related]
4. Recalcitrant cicatricial pemphigoid treated with the anti-TNF-alpha agent etanercept.
Kennedy JS; Devillez RL; Henning JS
J Drugs Dermatol; 2010 Jan; 9(1):68-70. PubMed ID: 20120429
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of etanercept in anti-laminin 5 (laminin 332) mucous membrane pemphigoid.
Schulz S; Deuster D; Schmidt E; Bonsmann G; Beissert S
Int J Dermatol; 2011 Sep; 50(9):1129-31. PubMed ID: 22126878
[No Abstract] [Full Text] [Related]
6. Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept).
Pastor N; Betlloch I; Pascual JC; Blanes M; Bañuls J; Silvestre JF
Clin Exp Dermatol; 2006 Jan; 31(1):152-3. PubMed ID: 16309525
[No Abstract] [Full Text] [Related]
7. Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor alpha antagonist etanercept.
Sacher C; Rubbert A; König C; Scharffetter-Kochanek K; Krieg T; Hunzelmann N
J Am Acad Dermatol; 2002 Jan; 46(1):113-5. PubMed ID: 11756956
[TBL] [Abstract][Full Text] [Related]
8. Adolescent plaque psoriasis: our experience using etanercept.
Ruiz-Villaverde R; Sánchez-Cano D; Abalos-Medina G
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):976-7. PubMed ID: 19207668
[No Abstract] [Full Text] [Related]
9. Etanercept in psoriasis treatment.
Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
[TBL] [Abstract][Full Text] [Related]
10. Treatment of coexisting bullous pemphigoid and psoriasis with the tumor necrosis factor antagonist etanercept.
Yamauchi PS; Lowe NJ; Gindi V
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S121-2. PubMed ID: 16488323
[No Abstract] [Full Text] [Related]
11. Life-table analysis of etanercept with or without methotrexate in patients with psoriatic arthritis.
Spadaro A; Ceccarelli F; Scrivo R; Valesini G
Ann Rheum Dis; 2008 Nov; 67(11):1650-1. PubMed ID: 18854519
[No Abstract] [Full Text] [Related]
12. Do we need treatment with tumour necrosis factor blockers for giant cell arteritis?
Salvarani C; Pipitone N; Boiardi L; Hunder GG
Ann Rheum Dis; 2008 May; 67(5):577-9. PubMed ID: 18408108
[No Abstract] [Full Text] [Related]
13. Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience.
Antoniou C; Dessinioti C; Stratigos A; Avgerinou G; Stavropoulos P; Katsambas A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):979-82. PubMed ID: 19470056
[No Abstract] [Full Text] [Related]
14. Successful use of infliximab following a failed course of etanercept in a pediatric patient.
Farnsworth NN; George SJ; Hsu S
Dermatol Online J; 2005 Dec; 11(3):11. PubMed ID: 16409907
[No Abstract] [Full Text] [Related]
15. Successful treatment of delayed pressure urticaria with anti-TNF-alpha.
Magerl M; Philipp S; Manasterski M; Friedrich M; Maurer M
J Allergy Clin Immunol; 2007 Mar; 119(3):752-4. PubMed ID: 17336621
[No Abstract] [Full Text] [Related]
16. [Cicatricial pemphigoid].
Babushkin AE
Vestn Oftalmol; 2005; 121(4):44-5. PubMed ID: 16223047
[No Abstract] [Full Text] [Related]
17. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment.
Hall VC; Liesegang TJ; Kostick DA; Lookingbill DP
Arch Dermatol; 2003 Aug; 139(8):1083-4. PubMed ID: 12925404
[No Abstract] [Full Text] [Related]
18. Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept.
Zeichner JA; Stern DW; Lebwohl M
J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S120-1. PubMed ID: 16488322
[No Abstract] [Full Text] [Related]
19. Etanercept, a tumour necrosis factor alpha receptor antagonist, and methotrexate in acute sensorineural hearing loss.
Street I; Jobanputra P; Proops DW
J Laryngol Otol; 2006 Dec; 120(12):1064-6. PubMed ID: 17040588
[TBL] [Abstract][Full Text] [Related]
20. QuantiFERON-TB Gold testing for tuberculosis in psoriasis patients commencing anti-tumour necrosis factor alpha therapy.
Desai N; Raste Y; Cooke NT; Harland CC
Br J Dermatol; 2008 May; 158(5):1137-8. PubMed ID: 18279462
[No Abstract] [Full Text] [Related]
[Next] [New Search]
